Observations with tinset tablet in allergic respiratory tract diseases.
The effect of Tinset tablet (30 mg oxatomide) has been examined in 68 patients suffering from allergic diseases of the upper respiratory tract or from allergic diseases accidentally accompanying different pulmonary diseases. In general the daily doses were 2 x 1 tab., occasionally 2 x 2 tab., a number of 12-16-year old patients received only 1 tab. daily. On the basis of the clinical symptoms, spirometric examinations, and global evaluation it has been concluded that the drug may be used most successfully in seasonal rhinitis, allergodermatosis, and allergic conjunctivitis cases and in extrinsic allergic asthma of children. The therapeutic effectiveness of the drug is insignificant in perennial rhinitis and adult extrinsic asthma cases. The somnolence-inducing effect of the drug is notable (it developed in 50% of the patients). In 23 of the 68 patients weight-gain, in 3 cases each gastric complaint or dryness of mouth developed.
Antmann
I
I
T. B. Dispensary, Outpatient Clinic, Dabas, Hungary.
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy; D002648:Child; D004341:Drug Evaluation; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D012130:Respiratory Hypersensitivity / Q000188:drug therapy*; D012220:Rhinitis / Q000188:drug therapy; D013607:Tablets
D006634:Histamine H1 Antagonists; D010879:Piperazines; D013607:Tablets; C015408:oxatomide